• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.

作者信息

Yamamoto Shintaro, Fujita Shunichi, Mukai Tomoyuki, Sawachika Hiroshi, Morita Yoshitaka

机构信息

Department of Rheumatology, Kawasaki Medical School, Japan.

出版信息

Intern Med. 2020 Feb 15;59(4):599. doi: 10.2169/internalmedicine.3938-19. Epub 2019 Oct 31.

DOI:10.2169/internalmedicine.3938-19
PMID:31666472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7056386/
Abstract
摘要

相似文献

1
Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.在帕博利珠单抗治疗期间，副肿瘤性缓解血清阴性对称性滑膜炎伴凹陷性水肿综合征应采用小剂量泼尼松龙治疗。
Intern Med. 2020 Feb 15;59(4):599. doi: 10.2169/internalmedicine.3938-19. Epub 2019 Oct 31.
2
Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.在帕博利珠单抗治疗期间，副肿瘤性缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征应采用小剂量泼尼松龙治疗。
Intern Med. 2020 Feb 15;59(4):597-598. doi: 10.2169/internalmedicine.3902-19. Epub 2019 Oct 31.
3
Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.一名肺癌患者同时出现巴泽克斯综合征和缓解型血清阴性对称性滑膜炎伴凹陷性水肿综合征
Intern Med. 2019 Nov 15;58(22):3267-3271. doi: 10.2169/internalmedicine.3032-19. Epub 2019 Jul 10.
4
Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.帕博利珠单抗和/或帕唑帕尼诱发的肾细胞癌患者缓解性血清阴性对称性滑膜炎伴凹陷性水肿
J Oncol Pharm Pract. 2020 Jul;26(5):1230-1233. doi: 10.1177/1078155219884113. Epub 2019 Nov 17.
5
Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma.帕博利珠单抗治疗肺鳞癌致缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征。
Intern Med. 2024 Jul 15;63(14):2089-2096. doi: 10.2169/internalmedicine.2475-23. Epub 2023 Dec 11.
6
Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.缓解期血清阴性对称性滑膜炎伴凹陷性水肿综合征合并原发性肺癌
Int Cancer Conf J. 2016 Sep 26;6(1):16-21. doi: 10.1007/s13691-016-0264-8. eCollection 2017 Jan.
7
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.纳武单抗诱发黑色素瘤患者出现缓解性血清阴性对称性滑膜炎伴凹陷性水肿：一例报告
J Med Case Rep. 2018 Feb 26;12(1):48. doi: 10.1186/s13256-018-1579-1.
8
Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema.副肿瘤性缓解型血清阴性对称性滑膜炎伴凹陷性水肿
Clin Exp Rheumatol. 1999 Nov-Dec;17(6):741-4.
9
[Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome)].两例具有类风湿关节炎样和系统性红斑狼疮样特征的病例，类似于伴有凹陷性水肿的缓解性血清阴性对称性滑膜炎（RS3PE综合征）
Ryumachi. 1993 Apr;33(2):162-8.
10
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Complicated with Organizing Pneumonia.伴有凹陷性水肿综合征并合并机化性肺炎的缓解型血清阴性对称性滑膜炎
Intern Med. 2020 Apr 15;59(8):1065-1069. doi: 10.2169/internalmedicine.3713-19. Epub 2020 Jan 17.

本文引用的文献

1
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.基线类固醇对非小细胞肺癌患者程序性细胞死亡-1 和程序性死亡配体 1 阻断疗效的影响。
J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.
2
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.帕博利珠单抗对比化疗用于 PD-L1 阳性非小细胞肺癌。
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.